Lexicon Pharmaceuticals Newsroom

H.C. Wainwright Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating, Maintains Target Price $10

Futu NewsOct 22 22:31

Piper Sandler Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating, Maintains Target Price $10

Futu NewsOct 17 19:36

Lexicon Pharmaceuticals Analyst Ratings

BenzingaOct 17 19:10

H.C. Wainwright Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating, Maintains Target Price $10

Futu NewsOct 17 18:35

Strategic Partnership and Financial Incentives Drive Buy Rating for Lexicon Pharmaceuticals

TipRanksOct 17 18:27

Piper Sandler Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating, Maintains Target Price $10

Futu NewsOct 10 18:31

H.C. Wainwright Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating, Maintains Target Price $10

Futu NewsOct 3 18:31

Buy Rating Affirmed for Lexicon Pharmaceuticals Based on Sotagliflozin's Market Potential and Favorable Safety Data

TipRanksOct 3 18:22

H.C. Wainwright Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating, Maintains Target Price $10

Futu NewsSep 27 23:32

HC Wainwright & Co. Reiterates Buy on Lexicon Pharmaceuticals, Maintains $10 Price Target

BenzingaSep 27 23:23

Lexicon Pharmaceuticals Analyst Ratings

BenzingaSep 27 23:22

H.C. Wainwright Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating, Maintains Target Price $10

Futu NewsSep 11 18:31

H.C. Wainwright Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating, Maintains Target Price $10

Futu NewsSep 3 23:31

HC Wainwright & Co. Reiterates Buy on Lexicon Pharmaceuticals, Maintains $10 Price Target

BenzingaAug 22 00:42

Lexicon Pharmaceuticals Analyst Ratings

BenzingaAug 22 00:42

H.C. Wainwright Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating, Maintains Target Price $10

Futu NewsAug 21 22:31

Buy Rating for Lexicon Pharmaceuticals Amid Positive Regulatory and Clinical Developments for ZYNQUISTA

TipRanksAug 21 22:02

Lexicon Pharmaceuticals Analyst Ratings

BenzingaAug 14 02:32

HC Wainwright & Co. Reiterates Buy on Lexicon Pharmaceuticals, Maintains $10 Price Target

BenzingaAug 14 02:32

H.C. Wainwright Maintains Lexicon Pharmaceuticals(LXRX.US) With Buy Rating, Maintains Target Price $10

Futu NewsAug 14 00:32